Comparing different suturing techniques for wound recovery after hip surgery
The Effect of Suturing Techniques on Aberrant Wound Recovery After Total Hip Arthroplasty
This study is testing which of four different stitching methods after hip surgery helps wounds heal better and faster for patients.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 236 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Reinier Haga Orthopedisch Centrum Academic / other |
| Locations | 1 site (Zoetermeer, South Holland) |
| Trial ID | NCT06275776 on ClinicalTrials.gov |
What this trial studies
This prospective randomized trial investigates the effects of four suturing techniques on wound healing disturbances following total hip arthroplasty. Participants will undergo surgery and have their wounds assessed through photographs taken at home and during follow-up visits. The study aims to determine which suturing method results in the least aberrant wound recovery within 14 days post-surgery. The techniques being compared include Monocryl, Vicryl Rapide with Indermil skin glue, Dermabond Prineo, and Stryker Zip.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older scheduled for total hip arthroplasty via the anterior approach at the RHOC.
Not a fit: Patients with prior hip surgeries or those unable to communicate in Dutch may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved wound healing outcomes for patients undergoing total hip arthroplasty.
How similar studies have performed: While the specific suturing techniques may be novel in this context, similar studies have shown varying success in improving wound recovery outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Eighteen years or older. * Scheduled to undergo Total Hip Arthroplasty via the anterior approach for any indication at the RHOC. * No prior operations to the hip which is to be operated on. * A good command of the Dutch language * Able to give written informed consent. Exclusion Criteria: * Usage of cytostatics in the period ranging from fourteen days prior, to ninety days after the operation. * Unable to, or difficulty with communicating in the Dutch language (e.g. due to mental disability, inability to understand/speak/write Dutch, et cetera).
Where this trial is running
Zoetermeer, South Holland
- Reinier Haga Orthopedisch Centrum — Zoetermeer, South Holland, Netherlands (Recruiting)
Study contacts
- Principal investigator: Stephan BW Vehmeijer, Dr. — Reinier Haga Orthopedisch Centrum
- Study coordinator: Brechtje Hesseling, Msc
- Email: onderzoek@rhoc.nl
- Phone: 003179-2065595
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.